24569-37-7

Upstream product

• 89-54-3 2-chloro-5-aminobenzoic acid 

Downstream Products

• 184163-49-3 2-chloro-5-hydrazinobenzoic acid hydrochloride 
• 1135871-42-9 5-(5-acetylfuran-2-yl)-2-chlorobenzoic acid 
• 1135871-46-3 5-(5-acetyl-1-methyl-1H-pyrrol-2-yl)-2-chlorobenzoic acid 
• 1135871-47-4 2-chloro-5-(2-acetyl-N-methylpyrrolyl)-N-methanesulfonylbenzamide 
• 1135869-46-3 N-methanesulphonyl-5-[5-[l-(2-benzothiazolylhydrazono)ethyl]-2-(N-methylpyrrolyl)]-2-chloro-benzamide 

Relevant academic research and scientific papers

BENZOTHIAZOLE COMPOUNDS

The present invention relates to benzothiazole compounds that mimic the activity of BH3 only proteins and are capable of binding to and neutralizing pro survival Bcl 2 proteins. The invention also relates to the use of such compounds in the regulation of cell death or cell survival and the treatment and/or prophylaxis of diseases or conditions associated with the deregulation of cell death or cell survival.

PYRAZOLO[3,4-B]PYRIDIN-2-YL]-BENZOIC ACID DERIVATIVES AS HIV INTEGRASE INHIBITORS

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein Cx, m, n, R1, R2, R3, R4, R5, R6, R7, Ra, Rs

Dihydrodipyrazolopyridinylbenzamide and -sulfonamide inhibitors of B7-1

The present invention provides a compound of formula I and the use thereof for the immunotherapeutic treatment of transplant rejection or autoimmune disease.